← Back
$SMMT All transactions

Summit Therapeutics Inc.

A

$ Value

Shares

400,000

Price

Filed

May 1

Insider

Name

Zanganeh Mahkam

Title

Co-Chief Executive Officer

CIK

0001507650

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-04-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

400,000

Footnotes

Effective April 29, 2025, these stock options were amended from performance-based stock options to time-based stock options. The shares underlying the option vest as follows: (i) 50% of such shares vested as of April 29, 2025, and (ii) the remaining 50% of such shares vest in three equal annual installments, with the first such installment occurring on October 13, 2025. | Not applicable.

Filing Info

Accession No.

0001599298-25-000091

Form Type

4

Issuer CIK

0001599298

Zanganeh Mahkam's History

Date Ticker Type Value
2026-01-02 SMMT A $98K
2025-10-21 SMMT A $5.0M
2025-10-21 SMMT $500K
2025-10-21 SMMT A $262.0M
2025-09-11 SMMT $90K
2025-09-10 SMMT $5.9M
2025-08-15 PLSE A $0
2025-08-15 PLSE A $0
2025-05-30 SMMT M $197K
2025-05-30 SMMT M $0

Other Insiders at SMMT (90d)

No other insider activity at this issuer in the last 90 days.